Screener
Asset Entities ASST Medical Device — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Net unrealized loss on investments in preferred equity, at fair value | (5,962) | — |
| Other investment loss | (2,801) | — |
| Total investment losses | (236,794) | — |
| Net operating loss | (258,249) | (3,690) |
| Other income/(expense): | ||
| Other income | 955 | 252 |
| Interest expense on long-term notes payable, at fair value | (40) | — |
| Change in fair value on long-term notes payable, at fair value | (299) | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — operating income (loss)?
- Asset Entities (ASST) reported medical device — operating income (loss) of -$5.22M in Q2 2026.
- What does medical device — operating income (loss) mean?
- This is the profit or loss generated by the business segment after subtracting all operating expenses from total segment revenues. It serves as the primary measure of the segment's core operational profitability and financial health. A positive value indicates a self-sustaining business unit, while a loss may signal a need for strategic restructuring.
Ask your AI about Asset Entities's medical device — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude